MetLife Investment Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$20.8M Buy
398,922
+55,181
+16% +$2.87M 0.12% 144
2025
Q1
$21.9M Buy
343,741
+198,476
+137% +$12.7M 0.12% 134
2024
Q4
$6.95M Buy
145,265
+10,538
+8% +$504K 0.04% 392
2024
Q3
$7.71M Sell
134,727
-2,098
-2% -$120K 0.04% 336
2024
Q2
$7.16M Sell
136,825
-159
-0.1% -$8.33K 0.04% 329
2024
Q1
$5.57M Sell
136,984
-3,133
-2% -$127K 0.04% 429
2023
Q4
$5.18M Sell
140,117
-1,071
-0.8% -$39.6K 0.04% 432
2023
Q3
$5.39M Sell
141,188
-5,603
-4% -$214K 0.04% 379
2023
Q2
$5.29M Sell
146,791
-3,081
-2% -$111K 0.04% 408
2023
Q1
$5.72M Sell
149,872
-2,225
-1% -$85K 0.04% 374
2022
Q4
$8.65M Sell
152,097
-5,690
-4% -$324K 0.07% 240
2022
Q3
$6.24M Buy
157,787
+517
+0.3% +$20.4K 0.05% 314
2022
Q2
$6.92M Sell
157,270
-5,144
-3% -$226K 0.05% 285
2022
Q1
$6.48M Buy
162,414
+46,458
+40% +$1.85M 0.04% 384
2021
Q4
$4.66M Sell
115,956
-2,605
-2% -$105K 0.04% 432
2021
Q3
$4.82M Buy
118,561
+1,501
+1% +$61.1K 0.04% 384
2021
Q2
$5.32M Buy
117,060
+1,195
+1% +$54.3K 0.05% 361
2021
Q1
$4.83M Sell
115,865
-6,803
-6% -$284K 0.04% 409
2020
Q4
$5.24M Buy
122,668
+62,759
+105% +$2.68M 0.05% 345
2020
Q3
$1.57M Hold
59,909
0.02% 826
2020
Q2
$1.61M Buy
59,909
+2,612
+5% +$70K 0.02% 816
2020
Q1
$1.03M Sell
57,297
-7,206
-11% -$130K 0.01% 891
2019
Q4
$1.14M Hold
64,503
0.01% 1029
2019
Q3
$1M Hold
64,503
0.01% 1068
2019
Q2
$1.11M Buy
64,503
+8,770
+16% +$151K 0.01% 1062
2019
Q1
$897K Hold
55,733
0.01% 1126
2018
Q4
$815K Hold
55,733
0.01% 1103
2018
Q3
$1.01M Hold
55,733
0.01% 1112
2018
Q2
$940K Hold
55,733
0.01% 1046
2018
Q1
$1.09M Hold
55,733
0.01% 971
2017
Q4
$1.13M Buy
+55,733
New +$1.13M 0.01% 985